A 38-year-old woman with MDD fails two adequate trials of SSRIs. She has no contraindications. Which augmentation strategy has the strongest evidence for treatment-resistant depression?
-
A
Adding buspirone
-
B
Adding lithium or atypical antipsychotic
-
C
Switching to a tricyclic antidepressant only
-
D
Adding methylphenidate